Psychedelic Stocks

Research Finds That People Used Psychedelics in Bronze Age

A new study has found that ancestors in the Bronze Age frequently indulged in psychedelics. The Bronze Age is a historic period that lasted between 3300 BC–1200 BC. This period got its name from the use of bronze, marking the maiden time people started working with metal.

The study found that humans living on Menorca, one of the Balearic Islands in the Mediterranean Sea that belong to Spain, regularly consumed mind-altering substances extracted from plants. Researchers confirmed this by analyzing hair samples retrieved from a burial site thought to be from the Bronze Age. Their discovery represents the first confirmed evidence that ancient peoples of this Spanish island used psychedelic drugs.

The research was conducted by a team of researchers from Spain, led by Professor Elisa Guerra Doce of the University of Valladolid. Doce has specialized in archaeology and prehistory.

The scientists used a combination of anthropology, archaeology, pharmacology, chemistry, iconography and ethnobotany to trace the consumption of these plants to prehistoric times in South America, Eurasia and North America. For their study, the researchers used high-resolution mass spectroscopy and ultra-high performance liquid chromatography to test various chemicals in the hair strands, which led to the discovery of psychoactive compounds in a trio of the samples.

The compounds found include ephedrine, a stimulant which can be extracted from certain species of pine shrubs and trees; and scopolamine and atropine, which are extracted from nightshade plants. The nightshade plant chemicals are known to cause alterations in perception and induce hallucinations, while ephedrine increases alertness and boosts energy levels.

Researchers theorize that the ancient peoples mainly used these hallucinogens during religious ceremonies or rituals, particularly those organized by shamans specialized in exploring altered-mind states. They believe that it wouldn’t have been hard for our ancient ancestors to find sources of these drugs, especially given their knowledge on the types of plants found on the island.

In addition to this, the scientists found wooden containers with circles they believe were meant to portray eyes. They postulate that the containers were used as time capsules to preserve records of specific metaphysical and cultural traditions that were done away with thousands of years ago.

The researchers’ findings offer a better understanding of the tradition of consuming psychedelic plants in ancient times. The study was published in the “Scientific Reports” journal. Other researchers involved include C. Rihuete-Herrada, H. M. Niemeyer, R. Risch, R. Micó and V. Lull.

With such a long history of use, psychedelics could be set for a major comeback as startups such as Compass Pathways PLC. (NASDAQ: CMPS) work to develop medicines targeting a number of clinical indications.

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)

For more information please visit https://www.psychedelicnewswire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com

PsychedelicNewsWire is part of the InvestorBrandNetwork.

Chris@PNW

Share
Published by
Chris@PNW

Recent Posts

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Pursues Dual Pathway for Preservative-Free Ketamine-Based Therapies

The company has refiled its Abbreviated New Drug Application (“ANDA”) for KETAFREE(TM), a preservative-free IV…

6 days ago

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Gains FDA Nod for Preservative-Free Ketamine Suitability Petition

FDA grants NRx Pharmaceuticals approval of a Suitability Petition for single-patient preservative-free ketamine. The decision…

2 weeks ago

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Secures FDA Fast Track for IV Ketamine Formulation NRX-100 in Suicidal Depression

The FDA designation expands the drug’s potential patient pool tenfold, to an estimated 13 million…

2 months ago

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Seeks FDA Ban on Toxic Ketamine Preservative

NRx Pharmaceuticals has filed a Citizen Petition with the FDA to remove benzethonium chloride from…

2 months ago

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Subsidiary to Acquire 49% Stake in Prominent Florida Neuropsychiatry Clinic

The acquisition of Cohen and Associates, a respected interventional psychiatry practice, by NRx subsidiary HOPE…

4 months ago

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Applies for FDA Commissioner’s National Priority Voucher for IV Ketamine NRX-100

The new FDA voucher program aims to speed approval of drugs aligned with national health…

4 months ago